Skip to main content
Top
Published in: Obesity Surgery 6/2020

01-06-2020 | Bariatric Surgery | Original Contributions

Hepatic Function and Fibrosis Assessment Via 2D-Shear Wave Elastography and Related Biochemical Markers Pre- and Post-Gastric Bypass Surgery

Authors: Tannaz Jamialahmadi, Ali Jangjoo, Reza Rezvani, Ladan Goshayeshi, Aida Tasbandi, Mehdi Jabbari Nooghabi, Farnood Rajabzadeh, Kamran Ghaffarzadegan, Zeinab Javid Mishamandani, Mohsen Nematy

Published in: Obesity Surgery | Issue 6/2020

Login to get access

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) exhibits a worldwide distribution and encompasses a wider range of hepatic abnormalities that can culminate in serious clinical outcomes. The growing incidence of NAFLD necessitates more efficient management strategies particularly in clinically severe obese patients. Weight reduction is the cornerstone of NAFLD treatment; therefore, bariatric surgery could be a therapeutic approach in selected obese patients afflicted with NAFLD and other cardiometabolic comorbidities.

Objective

The present study focused on the potential role of bariatric surgery on hepatic function and NAFLD-related histopathological features measured through a noninvasive method.

Method

Ninety patients entered to this study and underwent initial preoperative assessments including demographic profile, anthropometric measurements, standard laboratory tests, and hepatic biopsy. Liver stiffness was also evaluated via two-dimensional shear wave elastography (2D-SWE). All assessments were repeated over the subsequent 6 months following surgery except for liver biopsy.

Results

Postoperative hepatic elasticity was lessened after 6 months (p = 0/002).The levels of alanine aminotransferase, gamma-glutamyl transferase, total protein, lipid indices, glucose, and platelet count were also improved following surgery (p < 0/001). Further progression of fibrosis was observed in 25% of patients after surgery.

Conclusion

Bariatric surgery was associated with a favorable impact on anthropometric and hepatic elasticity indices as well as metabolic parameters. The ideal target population for bariatric surgery should be thoroughly addressed, and the underlying risk factors for fibrosis progression need to be controlled before surgery. However, expanded research designed as comprehensive randomized controlled trials are recommended to confirm these findings.
Literature
1.
go back to reference Lammers WJ, van Tilburg AJ, Apers JA, et al. Liver failure caused by prolonged state of malnutrition following bariatric surgery. World J Hepatol. 2018;10(3):396–9.CrossRef Lammers WJ, van Tilburg AJ, Apers JA, et al. Liver failure caused by prolonged state of malnutrition following bariatric surgery. World J Hepatol. 2018;10(3):396–9.CrossRef
2.
go back to reference Weiss J, Rau M, Meertens J, et al. Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe. Scand J Gastroenterol. 2016;51(10):1263–8.CrossRef Weiss J, Rau M, Meertens J, et al. Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe. Scand J Gastroenterol. 2016;51(10):1263–8.CrossRef
3.
go back to reference Garg H, Aggarwal S, Shalimar, et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis. 2018;14(1):81–91.CrossRef Garg H, Aggarwal S, Shalimar, et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis. 2018;14(1):81–91.CrossRef
4.
go back to reference Bende F, Mulabecirovic A, Sporea I, et al. Assessing liver stiffness by 2-D shear wave elastography in a healthy cohort. Ultrasound Med Biol. 2018;44(2):332–41.CrossRef Bende F, Mulabecirovic A, Sporea I, et al. Assessing liver stiffness by 2-D shear wave elastography in a healthy cohort. Ultrasound Med Biol. 2018;44(2):332–41.CrossRef
5.
go back to reference Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99(5):1408–13.CrossRef Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99(5):1408–13.CrossRef
6.
go back to reference Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. J Korean Med Sci. 1995;10(6):414–21.CrossRef Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. J Korean Med Sci. 1995;10(6):414–21.CrossRef
7.
go back to reference Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27(1):103–7.CrossRef Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27(1):103–7.CrossRef
8.
go back to reference Deng H, Qi X. Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(1):91–8.CrossRef Deng H, Qi X. Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(1):91–8.CrossRef
9.
go back to reference Jamialahmadi T, Nematy M, Jangjoo A, et al. Measurement of liver stiffness with 2D-shear wave Elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg. 2019;29(8):2585–92.CrossRef Jamialahmadi T, Nematy M, Jangjoo A, et al. Measurement of liver stiffness with 2D-shear wave Elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg. 2019;29(8):2585–92.CrossRef
10.
go back to reference Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999;22(5):818–22.CrossRef Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999;22(5):818–22.CrossRef
11.
go back to reference Jo V. Cytopathology, An Issue of Surgical Pathology Clinics: Elsevier Health Sciences; 2018. Jo V. Cytopathology, An Issue of Surgical Pathology Clinics: Elsevier Health Sciences; 2018.
12.
go back to reference Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598–607.e2.CrossRef Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598–607.e2.CrossRef
13.
go back to reference Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–73.CrossRef Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–73.CrossRef
14.
go back to reference Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–7.CrossRef Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–7.CrossRef
15.
go back to reference Yeo SC, Ong WM, Cheng KSA, et al. Weight loss after bariatric surgery predicts an improvement in the non-alcoholic fatty liver disease (NAFLD) fibrosis score. Obes Surg. 2019;29(4):1295–300.CrossRef Yeo SC, Ong WM, Cheng KSA, et al. Weight loss after bariatric surgery predicts an improvement in the non-alcoholic fatty liver disease (NAFLD) fibrosis score. Obes Surg. 2019;29(4):1295–300.CrossRef
16.
go back to reference Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532–40.CrossRef Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532–40.CrossRef
17.
go back to reference Ooi GJ, Burton PR, Doyle L, et al. Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease. Obes Surg. 2017;27(6):1533–42.CrossRef Ooi GJ, Burton PR, Doyle L, et al. Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease. Obes Surg. 2017;27(6):1533–42.CrossRef
18.
go back to reference Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–36. discussion 36-7CrossRef Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–36. discussion 36-7CrossRef
19.
go back to reference Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49(3):1017–44.CrossRef Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49(3):1017–44.CrossRef
20.
go back to reference Schwenger KJ, Fischer SE, Jackson T, et al. In nonalcoholic fatty liver disease, roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. Surg Obes Relat Dis. 2018;14(9):1233–9.CrossRef Schwenger KJ, Fischer SE, Jackson T, et al. In nonalcoholic fatty liver disease, roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. Surg Obes Relat Dis. 2018;14(9):1233–9.CrossRef
21.
go back to reference Caiazzo R, Lassailly G, Leteurtre E, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893–8. discussion 8-9CrossRef Caiazzo R, Lassailly G, Leteurtre E, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893–8. discussion 8-9CrossRef
22.
go back to reference Diniz Mde F, Diniz MT, Sanches SR, et al. Elevated serum parathormone after roux-en-Y gastric bypass. Obes Surg. 2004;14(9):1222–6.CrossRef Diniz Mde F, Diniz MT, Sanches SR, et al. Elevated serum parathormone after roux-en-Y gastric bypass. Obes Surg. 2004;14(9):1222–6.CrossRef
23.
go back to reference Nickel F, Tapking C, Benner L, et al. Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year follow-up : BariScan study. Obes Surg. 2018;28(5):1342–50.CrossRef Nickel F, Tapking C, Benner L, et al. Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year follow-up : BariScan study. Obes Surg. 2018;28(5):1342–50.CrossRef
24.
go back to reference Aldoheyan T, Hassanain M, Al-Mulhim A, et al. The effects of bariatric surgeries on nonalcoholic fatty liver disease. Surg Endosc. 2017;31(3):1142–7.CrossRef Aldoheyan T, Hassanain M, Al-Mulhim A, et al. The effects of bariatric surgeries on nonalcoholic fatty liver disease. Surg Endosc. 2017;31(3):1142–7.CrossRef
25.
go back to reference Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242(4):610.PubMedPubMedCentral Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242(4):610.PubMedPubMedCentral
26.
go back to reference Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–22.CrossRef Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–22.CrossRef
27.
go back to reference Bower G, Toma T, Harling L, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015;25(12):2280–9.CrossRef Bower G, Toma T, Harling L, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015;25(12):2280–9.CrossRef
28.
go back to reference Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266(5):738–45.CrossRef Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266(5):738–45.CrossRef
29.
go back to reference Jaimungal S, Wehmeier K, Mooradian AD, et al. The emerging evidence for vitamin D–mediated regulation of apolipoprotein AI synthesis. Nutr Res. 2011;31(11):805–12.CrossRef Jaimungal S, Wehmeier K, Mooradian AD, et al. The emerging evidence for vitamin D–mediated regulation of apolipoprotein AI synthesis. Nutr Res. 2011;31(11):805–12.CrossRef
30.
go back to reference Peat CM, Kleiman SC, Bulik CM, et al. The intestinal microbiome in bariatric surgery patients. Eur Eat Disord Rev. 2015;23(6):496–503.CrossRef Peat CM, Kleiman SC, Bulik CM, et al. The intestinal microbiome in bariatric surgery patients. Eur Eat Disord Rev. 2015;23(6):496–503.CrossRef
31.
go back to reference Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4(2):287–302.CrossRef Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4(2):287–302.CrossRef
Metadata
Title
Hepatic Function and Fibrosis Assessment Via 2D-Shear Wave Elastography and Related Biochemical Markers Pre- and Post-Gastric Bypass Surgery
Authors
Tannaz Jamialahmadi
Ali Jangjoo
Reza Rezvani
Ladan Goshayeshi
Aida Tasbandi
Mehdi Jabbari Nooghabi
Farnood Rajabzadeh
Kamran Ghaffarzadegan
Zeinab Javid Mishamandani
Mohsen Nematy
Publication date
01-06-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04452-0

Other articles of this Issue 6/2020

Obesity Surgery 6/2020 Go to the issue